Atlas Venture Life Science Advisors, LLC Day One Biopharmaceuticals, Inc. Transaction History
Atlas Venture Life Science Advisors, LLC
- $341 Million
- Q1 2025
A detailed history of Atlas Venture Life Science Advisors, LLC transactions in Day One Biopharmaceuticals, Inc. stock. As of the latest transaction made, Atlas Venture Life Science Advisors, LLC holds 6,430,257 shares of DAWN stock, worth $44.7 Million. This represents 14.93% of its overall portfolio holdings.
Number of Shares
6,430,257
Previous 6,430,257
-0.0%
Holding current value
$44.7 Million
Previous $81.5 Million
37.41%
% of portfolio
14.93%
Previous 13.44%
Shares
6 transactions
Others Institutions Holding DAWN
# of Institutions
196Shares Held
76.7MCall Options Held
138KPut Options Held
208K-
Vanguard Group Inc Valley Forge, PA5.94MShares$41.3 Million0.0% of portfolio
-
Ra Capital Management, L.P. Boston, MA5.76MShares$40 Million0.95% of portfolio
-
Black Rock Inc. New York, NY4.53MShares$31.5 Million0.0% of portfolio
-
Alyeska Investment Group, L.P. Chicago, IL4.06MShares$28.2 Million0.14% of portfolio
-
Franklin Resources Inc San Mateo, CA4.02MShares$27.9 Million0.01% of portfolio
About Day One Biopharmaceuticals, Inc.
- Ticker DAWN
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 73,461,104
- Market Cap $511M
- Description
- Day One Biopharmaceuticals, Inc., a clinical-stage biopharmaceutical company, develops and commercializes targeted therapies for patients with genetically defined cancers. Its lead product candidate is DAY101, an oral brain-penetrant type II pan-rapidly accelerated fibrosarcoma kinase inhibitor that is in Phase II clinical trial for pediatric pa...